Our Science
Our innovative product solutions optimise the performance of active ingredients.
We have multiple published and unpublished studies, with an ongoing calendar of human pharmacokinetic and clinical studies.
Research and Development
With our approach we have developed 4 uniquely distinct and scientifically proven, delivery system technologies, that redefine the boundaries of nutrient efficacy and efficiency.
An unwavering dedication to scientific validation ensures that every product is backed by robust evidence, providing healthcare professionals and consumers with the confidence they deserve.
A calendar of human clinical studies and trials combined with our commitment to continuing scientific validation of our formulations, while working hand in hand with respected universities, researchers and CRO’s both in Australia and abroad, drives innovation forward.
Quality Standards
Pharmako is GMP certified by the Therapeutic Goods Administration, and as such adheres to some of the most rigorous safety and quality standards in the world. Unlike many other countries, Australia regulates complementary medicines within the same legal framework as pharmaceutical drugs.
Pharmako’s Quality Management System is a benchmark for pharmaceutical manufacturing facilities, ensuring that raw materials and finished products are controlled at all stages, from receipt to release. All aspects of compliance and tracking are built in to ensure we operate with the highest standard.
Each one of our products passes more than 30 rigorous quality tests and checks during all stages of the manufacturing process, prior to being released from our facility.
Driven by Science
Innovation, scientific credibility and strict quality standards are key to setting us apart, we have:
30+
completed human pharmacokinetic and clinical trials.
20+
published papers in high impact international scientific journals.
4
patented/patent pending major technologies that are commercialised in global markets.
5
in-house laboratories, including R&D, wet labs and state-of-the-art testing facilities.
30+
every product passes over 30 quality tests and checks during all stages of the manufacturing process.
Published Studies
-
HydroCurc® Reduced inflammatory responses post Covid-19.
A new published study highlights the impact of HydroCurc® supplementation on the immune response in post COVID-19 vaccinated adults.
Nutrients Journal
23 Mar 2023
-
HydroCurc® Decreasing joint pain and improving quality of life.
A short 2 week study has demonstrated that a single dose of bioavailable curcumin, HydroCurc® is an effective option for rapidly reducing joint pain.
Complement Med Res
Dec 2022
-
HydroCurc® + FS iron, Reduces inflammation markers.
The 3rd study by University of Westminster on HydroCurc® co-supplemented with Ferrous Sulphate, has shown a reduction in oxidative stress and systemic-inflammation.
Nutrients journal
8 February 2022
-
HydroCurc® + FS iron Has no impairment on iron absorption.
The 2nd study conducted by the University of Westminster has demonstrated that supplementation of HydroCurc® with Ferrous Sulphate, does not negatively influence acute iron absorption in healthy adults, as previously thought.
Nutrients journal
3 July 2021
-
Levagen®+ Palmitoylethanolamide Minimises Sleep Disturbance.
This study aimed to asses the impact on sleep measures when administered Levagen®+ at a 350mg dose. The findings support Levagen®+ as a potential sleeping aid capable of reducing sleep onset time and improving cognition on waking.
Sleep, Science and Practice journal
September 2021
-
Veri-Sperse® Trans-resveratrol Optimised with LipiSperse® increases bioavailability.
This study showed that a single dose of trans-resveratrol with LipiSperse® resulted in a 1.6-fold increase in the resulting resveratrol-sulfate conjugate, and a 2-fold increase in glucuronide conjugate.
Pharmaceuticals journal
8 December 2020
-
HydroCurc® Improves Delayed Onset Muscle Soreness and Postexercise Lactate Accumulation.
The efficacy of curcumin supplementation is traditionally limited due to its poor bioavailability, however curcumin has previously been shown to improve biomarkers of muscle damage.
Journal of Dietary Supplements
24 July 2020
-
HydroCurc® + FS iron Increases BDNF serum levels
A large study (n=150) conducted at Westminster University has shown that supplementing HydroCurc® with iron significantly increases serum BDNF (Brain-Derived Neurotrophic Factor) levels which cross the blood brain barrier, essential for neuronal health. HydroCurc® increases the absorption and tolerance of iron which is essential for cognitive health.
Antioxidants journal
22 July 2020
-
Levagen®+ Enhanced absorption of PEA using LipiSperse®.
LipiSperse® dispersion technology as Levagen®+ has been used in a pharmacokinetic study to evaluate the absorption of Palmitoylethanolamide (PEA-Levagen®).
Journal of Nutraceuticals and Food Science.
3 May 2020
-
Levagen®+ Aids in muscle recovery.
The study aimed to compare the bioavailability of a single dose of commercially available PEA + LipiSperse® (the delivery complex) in an Exercise Study, demonstrating Levagen®+ aids in muscle recovery.
Nutrients journal.
25 Feb 2020
-
AquaCelle® Omega-3 Boosts EPA and DHA bioavailability.
The study assessed the ability of a self-emulsifying drug delivery system (SEDDS), AquaCelle®, as an additive to enhance the oral absorption of Omega-3 ethyl esters (EE) in healthy subjects under low-fat diet conditions.
European Journal of Nutrition
21 Oct 2019
-
AquaCelle® CoQ10 Impacts on micelle size and increases ubiquinone absorption.
The novel delivery system AquaCelle® demonstrated superior supply of ubiquinone (Q10) when compared with a standard ubiquinone extract.
International Journal of Pharmacokinetics
16 September 2019
-
Levagen®+ Treatment for decreasing pain and other symptoms of knee osteoarthritis.
The study was to assess the safety, tolerability and efficacy of palmitoylethanolamide (PEA) when dosed at 300 mg and 600 mg per day on symptoms of knee osteoarthritis.
Inflammopharmacology
29 March 2019
-
HydroCurc® Optimises bioavailability of curcumin with LipiSperse®.
The aim of this study was to investigate the pharmacokinetics of HydroCurc® (a commercially available curcumin extract), with or without the curcumin-LipiSperse® delivery complex.
European Journal of Nutrition
28 June 2018
